An official website of the United States government
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.










 
553 - 564 of 8831 results
Thumbnails List
San Diego. CA
250604-N-WJ173-1003 CAMP PENDLETON, Calif. (June 4, 2025) – Capt. Elizabeth Adriano, Naval Medical Readiness and Training Command San Diego commander, stands beside the printed program for the Get Real, Get Better (GRGB) Leadership Symposium at NMRTC Camp Pendleton, June 4, 2025. The event brought together leaders across Navy Medicine to promote a culture of accountability, transparency, and continuous improvement in support of operational excellence and warfighter readiness.The mission of NMCSD is to provide a superior experience for our patients, staff, and warfighters. NMCSD employs more than 5,000 active-duty military personnel, civilians, and contractors in Southern California to deliver exceptional care afloat and ashore.
San Diego. CA
250604-N-WJ173-1002 CAMP PENDLETON, Calif. (June 4, 2025) – Command Master Chief Adolfo Gonzalez, Naval Medical Readiness and Training Command San Diego senior enlisted leader, speaks during the "Building Trust & Leading Change: Senior Enlisted Perspective" panel at the Get Real, Get Better (GRGB) Leadership Symposium hosted at NMRTC Camp Pendleton, June 4, 2025. Gonzalez emphasized that trust is earned through consistency and accountability, and reinforced the vital role senior enlisted leaders play in upholding standards and building committed, high-performing teams. The GRGB initiative focuses on fostering a culture of ownership, transparency, and continuous improvement across Navy Medicine.The mission of NMCSD is to provide a superior experience for our patients, staff, and warfighters. NMCSD employs more than 5,000 active-duty military personnel, civilians, and contractors in Southern California to deliver exceptional care afloat and ashore.
San Diego. CA
250604-N-WJ173-1001 CAMP PENDLETON, Calif. (June 4, 2025) – Capt. Elizabeth Adriano, Naval Medical Readiness and Training Command San Diego commander, speaks during the "Senior Officer Leaders – Leadership Strategies for Cultivating Excellence" panel at the Get Real, Get Better (GRGB) Leadership Symposium hosted at NMRTC Camp Pendleton, June 4, 2025. Adriano emphasized that leadership is often about acting as a conduit—connecting teams to information and decisions at higher levels—while building trust through transparency and open communication. The GRGB initiative promotes continuous improvement, accountability, and trust across Navy Medicine. The mission of NMCSD is to provide a superior experience for our patients, staff, and warfighters. NMCSD employs more than 5,000 active-duty military personnel, civilians, and contractors in Southern California to deliver exceptional care afloat and ashore.
Frederick, MD
FREDERICK, Md. (April 11, 2025) Naval Medical Research Command (NMRC), conducts bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Naval Medical Research Command (NMRC), conducts bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
Frederick, MD
FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
BUMED Seal


Bureau of Medicine and Surgery
7700 Arlington Blvd. Ste. 5113 Falls Church, VA 22042-5113
This is an official U.S. Navy website
This is a Department of Defense (DoD) Internet computer system.

General Navy Medical Inquiries (to Bureau of Medicine and Surgery): usn.ncr.bumedfchva.list.bumed---pao@health.mil
 


Charlie Mike Flags
 

Facebook Icon   Twitter  Instagram  YouTube  LinkedIn  Flickr Internet Archive
Safe Helpline
Veterans Crisis Line
Northern Command: Dial 988 then Press 1
Pacific Command: Call +1 844-702-5493 (off base) or DSN 988 (on base)
European Command: Call +1 844-702-5495 (off base) or DSN 988 (on base)
Central Command: Call +1 855-422-7719 (off base) or DSN 988 (on base)
African Command: Call +1 888-482-6054 (off base) or DSN 988 (on base)
Southern Command: Call +1 866-989-9599 (off base) or DSN 988 (on base)
Guidance-Card-Icon Dept-Exclusive-Card-Icon